China's Chaoju Eye Care H1 net profit falls on lower insurance pricing

Chaoju Eye Care Holdings

28/08/2026 09:40

Overview
China ophthalmic medical group's H1 revenue rose 1.8% yr/yr, driven by consumer services growth
Net profit for H1 fell 16.1% yr/yr, with net margin narrowing to 13.1%
Gross profit margin declined due to lower medical insurance pricing and higher costs

Outlook
Company expects steady demand growth for ophthalmic services due to economic growth and aging population
Chaoju Eye Care plans to expand network in North China and Yangtze River Delta through acquisitions and new hospitals
Company aims to leverage clinical expertise to increase market share in consumer ophthalmic services

Result Drivers
CONSUMER OPHTHALMIC SERVICES - Co said revenue growth was mainly driven by consumer ophthalmic services, which benefited from increased procedure volume and higher pricing following the introduction of SMILE-PRO equipment
BASIC OPHTHALMIC SERVICES - Co said revenue from basic ophthalmic services declined due to reduced medical insurance pricing, though increased patient visits partially offset the impact
EQUIPMENT AND CONSUMABLE SALES - Sales revenue from medical equipment and consumables rose, reflecting expansion of the supply chain sales business

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
RMB 710.70 mln
 

Reuters Recommended Reads
Aug 25 - C-Mer Eye Care's H1 revenue rises, net profit flat
Aug 25 - Hong Kong's SV Vision H1 revenue dips
Aug 27 - China's Hygeia Healthcare H1 profit rises

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Press Release s3://eap-prd-eu-west-1-source-content/eap_feed_proxy/fingerpost/HKSW/2026-08-28/40e7bfa5-74fe-4df1-9575-ba533ff7dc6b.file
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)